Case Study
Understand the regulatory environment, treatment pathways and patient journey for rare diseases in targeted geographies
Jan 30, 2023

The treatment for rare diseases continue to grow and come into focus, understanding patient pathways and the current treatment landscape are key to strengthening patient access.

The case study shows how an established biopharmaceutical company commercialized their Neurology rare disease asset in Asia Pacific by developing a deeper understanding of the market dynamics in targeted markets and optimizing its go-to-market model.

IQVIA conducted a pre-launch study and helped the client generate key insights for launch optimization and devise a strategic GTM plan. Discover how you can identify new opportunities to drive a successful product launch and impact the patient journey.

Related solutions

Contact Us